PRVB
Provention Bio, Inc. Common Stock
PRVB
PRVB
Delisted
PRVB was delisted on the 26th of April, 2023.
120 hedge funds and large institutions have $248M invested in Provention Bio, Inc. Common Stock in 2021 Q1 according to their latest regulatory filings, with 29 funds opening new positions, 52 increasing their positions, 24 reducing their positions, and 15 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
120
Holders Change
+14
Holders Change %
+13.21%
% of All Funds
2.11%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
29
Increased
52
Reduced
24
Closed
15
Calls
$8.85M
Puts
$2.61M
Net Calls
+$6.24M
Net Calls Change
+$7.48M
Top Buyers
| 1 |
GGHC
1
Gilder Gagnon Howe & Co
New York
|
$32.6M |
| 2 |
2
Vanguard Group
Malvern,
Pennsylvania
|
$29.6M |
| 3 |
3
BlackRock
New York
|
$46.8M |
| 4 |
4
Two Sigma Advisers
New York
|
$9.45M |
| 5 |
5
Goldman Sachs
New York
|
$3.57M |
